3189 results for «645»
3189 results
PCR London Valves 2017 Opening Ceremony - Welcome address
25 Sep 2017 – From PCR London Valves 2017
Welcome to Imaging Day
24 Sep 2017 – From PCR London Valves 2017
Welcome and introduction to PCR Innovators Day London
24 Sep 2017 – From PCR Innovators Day 2017
AsiaPCR/SingLIVE 2018: Closing Ceremony and Awards
27 Jan 2018 – From AsiaPCR/SingLIVE 2018
Join U. Kaul, T.H. Koh and S.T. Lim for the AsiaPCR/SingLIVE 2018 Closing Ceremony if you want to find out who this year's Best Abstract and Best Clinical case award winners are?
PCR Tokyo Valves 2019 Opening Ceremony
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover the slides of PCR Tokyo Valves 2019 Opening Ceremony, a course which is expanding to become the major Asian forum in valvular interventions.
Closing Ceremony - PCR Tokyo Valves 2019
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover the slides of the PCR Tokyo Valves 2019 closing ceremony, including the best clinical case presenters awards.
Large-bore mechanical thrombectomy vs catheter-directed thrombolysis for treatment of intermediate-risk pulmonary embolism: primary outcomes from the PEERLESS randomized controlled trial
30 Oct 2024
Elad Asher provides his take on the PEERLESS trial presented by Wissam A. Jaber at TCT 2024 in Washington.
Author
How to close vascular access with a combined suture-/plug-based strategy using one ProStyle and one Angio-Seal in TAVI
29 Jan 2026
Large-bore femoral access closure remains a critical step in transfemoral TAVI, where access-site complications can significantly impact outcomes.
This My Toolkit article presents a step-by-step tutorial on a combined suture- and plug-based closure strategy using one ProStyle™ and one Angio-Seal®. The technique aims to achieve rapid, reliable...
Author
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
